文献速递骨质疏松与代谢性骨病创伤骨科

仅孕激素避孕与绝经前骨折风险:病例对照研究

Effect of progestogen-only contraception on premenopausal fracture risk: a case-control study.
PubMed 文献 · Osteoporos Int · 2020-05-06

基于疾病分析数据库的病例对照研究纳入14,421例16-55岁首次骨折女性并匹配14,421例对照,评估仅孕激素避孕(口服片与左炔诺孕酮宫内节育器)与骨折风险的关系。调整后分析显示,两类避孕方式的使用及使用时长均与骨折风险无显著关联,且在不同年龄组中均未观察到影响,提示其可能是骨安全的避孕选择。

要点

  • 仅孕激素口服避孕药与骨折风险无显著关联(OR=0.98,95%CI 0.90-1.07,p=0.657)。
  • 左炔诺孕酮宫内节育器与骨折风险无显著关联(OR=0.99,95%CI 0.81-1.21,p=0.945)。
  • 使用时长及不同年龄组均未见对骨折发生的影响。

核心结论

  • 仅孕激素避孕(口服片或左炔诺孕酮宫内节育器)与绝经前女性骨折风险无独立于年龄的关联,可能为成人及青少年的骨安全选择。

研究设计与样本

  • 基于疾病分析数据库的病例对照研究,纳入14,421例16-55岁首次诊断骨折的女性,并匹配14,421例随机对照。

主要发现

  • 调整后Logistic回归显示,仅孕激素口服避孕药使用与骨折无显著关联(OR=0.98,95%CI 0.90-1.07,p=0.657)。
  • 左炔诺孕酮宫内节育器使用与骨折无显著关联(OR=0.99,95%CI 0.81-1.21,p=0.945)。
  • 仅孕激素口服避孕药使用时长对骨折无显著影响(OR=1.01,95%CI 0.98-1.03,p=0.672)。
  • 左炔诺孕酮宫内节育器使用时长对骨折无显著影响(OR=0.94,95%CI 0.87-1.02,p=0.177)。

临床怎么用

  • 对于绝经前女性及青少年,仅孕激素避孕可视为骨安全性较好的避孕选择,但仍需结合个体情况综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Our study demonstrated that progestogen-only oral and intrauterine contraceptives are not associated with fracture risk independent from age. PURPOSE: The use of progestogen-only contraception, resulting in a hypoestrogenic state, has been associated with impaired bone acquisition and increased fracture risk. The aim of this large population-based study was to assess the fracture risk in association with the use of progestogen-only contraceptives (progestogen-only pills (POPs) and progestogen-containing IUDs (LNG-IUD)). METHODS: We identified 14,421 women between 16 and 55 years of age with a first-time diagnosis of fracture and matched them with 14,421 random controls using the Disease Analyzer Database. RESULTS: The results of the first adjusted logistic regression model (ever use vs. never use of progestogen-only contraceptives) revealed that there was no significant association between the use of POPs (OR = 0.98, 95% CI 0.90-1.07, p = 0.657) or LNG-IUDs (OR = 0.99, 95% CI 0.81-1.21, p = 0.945) and fracture incidence. Also, in the second regression model, we observed no effect of duration of use of POPs (OR = 1.01, 95% CI 0.98-1.03, p = 0.672) or LNG-IUDs (OR = 0.94, 95% CI 0.87-1.02, p = 0.177) on fracture occurrence. We also observed no effect in different age groups. CONCLUSION: Our study results indicate that progestogen-only contraception (either POPs or LNG-IUPs) is not associated with fracture risk and may be considered a bone-safe option for adults and adolescents.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Kyvernitakis I, Kostev K, Thomasius F, et al. Effect of progestogen-only contraception on premenopausal fracture risk: a case-control study. Osteoporos Int. 2020. PMID: 32377808. doi:10.1007/s00198-020-05437-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。